Clinical Trial Update: Immunochemotherapy With Rituximab-Bendamustine-Cytarabine (R-BAC) for Patients With Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Rituximab-Bendamustine-Cytarabine (R-BAC) for mantle cell lymphoma has completed; the update notes the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• CYTARABINE (CYTARABINE)
• Rituximab (rituximab)

Snippet

Sponsor: St. Bortolo Hospital | Conditions: Lymphoma, Mantle-Cell | Phase 2 | Status: COMPLETED